Showing results (1201-1210 of 9,422) with videos related to
Sort By:
Pageof 943
Clinical Endocrinology|June 21, 2005
Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based studyAnna-Lena Undén, Stig Elofsson, Kerstin BrismarClinical Endocrinology|February 1, 1992
Pituitary-ovarian function in women with minimal or mild endometriosis and otherwise unexplained infertilityK Bancroft, C A Vaughan Williams, M ElsteinClinical Endocrinology|February 1, 1992
Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinomaE Modigliani, R Cohen, S Joannidis, et al.Clinical Endocrinology|September 10, 2004
Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteersBarbara E Wolfe, David C Jimerson, Christine Orlova, et al.Clinical Endocrinology|September 10, 2004
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levelsEleonora Carosa, Paolo Martini, Fulvia Brandetti, et al.Clinical Endocrinology|September 10, 2004
Changes in endothelium-dependent arterial dilation before and after subtotal thyroidectomy in subjects with hyperthyroidismXiang Guang-da, Cao Hong-yan, Zeng Xian-meiClinical Endocrinology|July 27, 2004
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin statusRenato Cozzi, Roberto Attanasio, Sandro Lodrini, et al.Clinical Endocrinology|July 27, 2004
Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegalyHelen E Turner, Viv A Thornton-Jones, John A H WassClinical Endocrinology|July 27, 2004
The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy womenKi Won Oh, Eun Jung Rhee, Won Young Lee, et al.Clinical Endocrinology|July 27, 2004
A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK CaucasiansJoanne M Heward, Matthew J Simmonds, Jackie Carr-Smith, et al.Pageof 943